Author

Abdalla M. Wedn

University of PittsburghORCID 0000-0002-5768-9684Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Adrian V. LeeiD· 2 shared Geoffrey L. PecariD· 2 shared Steffi OesterreichiD· 2 shared Ye CaoiD· 2 shared Adam BrufskyiD· 1 shared Alan H. WellsiD· 1 shared Alexander Chih-Chieh ChangiD· 1 shared Amanda M. ClarkiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Adrian V. LeeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer

Alexander Chih-Chieh Chang, Marija Balić, Tanner L. Bartholow, Rohit Bhargava, Daniel D. Brown, Lauren Brown, Adam Brufsky, Ye Cao, Neil M. Carleton, Amanda M. Clark, Morgan Cody, Kai Ding, Christopher R. Deible, Ashuvinee Elangovan, Julia Foldi, , Steffi Oesterreich

The paper describes the Hope for Others rapid autopsy program for metastatic breast cancer, detailing its protocols, sample collection, and findings on metastasis research and model development.

Breast Cancer Research · Jun 19, 2025Peer-reviewedCancer Biology

Targeting RET in Brain Metastases from Estrogen Receptor Positive Breast Cancer

Simeng Liu, Geoffrey L. Pecar, Ye Cao, Fangyuan Chen, Abdalla M. Wedn, Jennifer M. Atkinson, Jagmohan Hooda, Steffi Oesterreich, Adrian V. Lee

This study identifies RET as a druggable target in estrogen receptor-positive breast cancer brain metastases and shows that Pralsetinib inhibits RET-driven metastatic properties.

bioRxiv · Apr 4, 2025 · PreprintCancer Biology